D64.0

Clinical Causes: Genetic mutations inherited from parents, mainly affecting the enzymes involved in heme synthesis Sex-linked inheritance pattern, often affecting males more frequently Mutations in genes such as ALAS2, which is critical for producing heme, a component of hemoglobin

Key Symptoms: Weakness and fatigue due to reduced oxygen delivery to tissues Pale skin and mucous membranes (pallor) Shortness of breath during exertion Headaches and dizziness Rapid heartbeat (tachycardia) In some cases, enlargement of the spleen (splenomegaly) Possible developmental delays in children, if hereditary form manifests early

Diagnosis Path: Complete blood count (CBC) to assess anemia and cell size Blood smear microscopy to observe abnormal red blood cells with ringed sideroblasts Bone marrow examination to visualize iron-loaded sideroblastic cells Iron studies to rule out other causes of anemia Genetic testing to identify mutations in specific genes like ALAS2 Family history evaluation to detect inheritance patterns

Treatment Protocols: Vitamin B6 (pyridoxine) supplements, which may improve hemoglobin production in certain cases Regular blood transfusions to treat severe anemia, with careful monitoring for iron overload Iron chelation therapy to remove excess iron resulting from transfusions Folic acid supplementation to support red blood cell production Monitoring and managing potential complications such as iron overload and splenomegaly Bone marrow transplantation in severe cases where other treatments fail